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Background: Yeast mating provides an efficient means for strain and library construction. However,
biotechnological applications of mating in the methylotrophic yeast Pichia pastoris have been hampered because
of concerns about strain stability of P. pastoris diploids. The aim of the study reported here is to investigate
heterologous protein expression in diploid P. pastoris strains and to evaluate diploid strain stability using high cell
density fermentation processes.
Results: By using a monoclonal antibody as a target protein, we demonstrate that recombinant protein production
in both wild-type and glycoengineered P. pastoris diploids is stable and efficient during a nutrient rich shake flask
cultivation. When diploid strains were cultivated under bioreactor conditions, sporulation was observed.
Nevertheless, both wild-type and glycoengineered P. pastoris diploids showed robust productivity and secreted
recombinant antibody of high quality. Specifically, the yeast culture maintained a diploid state for 240 h
post-induction phase while protein titer and N-linked glycosylation profiles were comparable to that of a haploid
strain expressing the same antibody. As an application of mating, we also constructed an antibody display library
and used mating to generate novel full-length antibody sequences.
Conclusions: To the best of our knowledge, this study reports for the first time a comprehensive characterization
of recombinant protein expression and fermentation using diploid P. pastoris strains. Data presented here support
the use of mating for various applications including strain consolidation, variable-region glycosylation antibody
display library, and process optimization.
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The methylotrophic yeast P. pastoris has become an in-
creasingly popular host for recombinant protein expres-
sion in recent times. As a eukaryote, P. pastoris has the
capability to perform various post-translational modifi-
cations such as glycosylation, disulphide isomerization,
proteolytic processing, and secretes correctly folded pro-
tein into culture media. P. pastoris can grow in methanol
to very high cell densities in bioreactors, exceeding
450 g/L wet cell weight (WCW). Being an obligate aer-
obe when fed with methanol, P. pastoris does not switch
to anaerobic metabolism that would lead to toxic* Correspondence: ming-tang.chen@merck.com;
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reproduction in any medium, provided the ormetabolite accumulation under oxygen limited condi-
tion. This makes it possible to run high cell density fer-
mentations under dissolved oxygen controlled processes.
Other benefits of the P. pastoris system include ease of
genetic manipulation, stable expression, rapid cell
growth, low-cost scalable fermentation processes and lit-
tle to no risk of human pathogenic virus contamination.
The P. pastoris system has been successfully used to
produce a wide variety of heterologous proteins [1]. Fer-
mentation titers at grams per liter scale have been
reported for several target proteins including full-length
antibodies [2-6].
In yeasts, the outer oligosaccharide chains of secreted
proteins are decorated with high mannose type glycans.
P. pastoris-derived glycosylated proteins are therefore
potentially immunogenic. To overcome this issue, wetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pression system that could produce glycoproteins with
glycosylation profiles similar to mammalian systems
[7-13]. Therapeutic glycoproteins produced by the
humanized P. pastoris platform have shown comparable
folding, stability, and in vitro and in vivo efficacies in
preclinical models to their counterparts produced from
the CHO platform [14-16].
Like S. cerevisiae, P. pastoris is an ascomycetous
homothallic budding yeast that can exist in both haploid
and diploid states. Most industrial yeasts are diploids or
polyploids. Diploid S. cerevisiae strains are generally
considered to have greater thermo-stability as well as a
higher tolerance to acid, ethanol, and other fermentation
inhibitors than haploid strains [17,18]. Breeding poly-
ploid industrial yeast strains has been shown to improve
ethanol productivity and protein production [19]. More-
over, mating of S. cerevisiae has been successfully
employed in other biotechnology and discovery applica-
tions such as yeast two-hybrid libraries [20] and anti-
body Fab display libraries [21]. In the case of an
antibody Fab mating library, small variable heavy and
light chain libraries are built and transformed separately
into two haploid yeast strains with opposite mating
types. Through mating of heavy and light chain haploid
libraries, a large combinatorial Fab library can be gener-
ated and displayed on the diploid yeast surface [21].
One of the major differences distinguishing P. pastoris
and S. cerevisiae mating is that P. pastoris is most stable
in the vegetative haploid state and remains haploid un-
less forced to mate under certain conditions such as ni-
trogen limited-starvation [22]. The mated diploid yeasts
efficiently undergo meiosis, sporulation, and switch back
to the haploid state upon nitrogen limitation and other
nutritional stresses. Due to the concern about diploid
stability, especially in bioreactor fermentation processes,
until now, no strategies have been described to utilize,
much less to comprehensively quantify, recombinant pro-
tein expression and fermentation using diploid P. pastoris
strains.
By using an IgG1 monoclonal antibody as the target
protein, here, we demonstrate that both wild-type and
glyco-engineered P. pastoris diploids provide stable and
efficient heterologous protein expression in a nutrient
rich shake flask environment. When the diploid strains
were run in simple fed-batch, carbon-limited fermenta-
tion processes, both wild-type and glyco-engineered dip-
loid strains afforded high protein productivity for at
least 240 hours post-induction. Despite the observation
of sporulation events happening during fermentation,
we provide evidence showing that the majority of the
yeast population maintained diploids in the 240 hour
methanol induction. Finally, we compare recombinant
protein productivities between a P. pastoris haploid IgG1production strain and its isogenic, homozygous diploid
clone. We show that diploid P. pastoris offers compar-
able protein productivity and N-glycosylation profile to
its haploid counterpart.
As an application of mating P. pastoris haploids, we
used mating to evaluate the ability of two libraries, one
light chain and one heavy chain to produce unique func-
tional antibody leads. The successful development of a
P. pastoris display mating library can streamline the
mAb discovery, maturation, and production in the
humanized glycoengineered P. pastoris platform, enab-
ling simultaneous screening of high affinity and satisfac-
tory expression antibody leads. As a proof-of-concept
study, we started with an IgG1 with a known affinity for
its antigen and designed a small sequence variation li-
brary focusing on heavy-chain and light-chain CDR3
regions. The library contained >4,000 heavy-chain var-
iants and >1,200 light-chain variants. Through mating
of heavy and light chain P. pastoris haploid libraries,
a diploid library containing more than 108 colonies
was successfully constructed, offering a greater than
10× coverage of the theoretical diversity.
Results
Construction of diploid P. Pastoris strains by mating
To demonstrate the feasibility of using diploid P. pas-
toris strains for heterologous protein expression, we
designed two expression vectors, pGLY10969 and
pGLY10970 encoding the protein sequences for the
light-chain and the heavy-chain of an anti-HER2 anti-
body, respectively. Their expressions are under the con-
trol of the AOX1 promoter and TEF transcriptional
terminator (Figure 1a and 1b). To ensure the mating,
two dominant selection markers are used, where plasmid
pGLY10969 uses the S. cerevisiae ARR3 gene (ARS, con-
fers resistance to arsenic) and plasmid pGLY10970 uses
the Streptomyces noursei nourseothricin acetyltransferase
gene (NAT, confers resistance to nourseothricin).
In order to understand the stability of diploids during
methanol induction, plasmid pGLY10969 contains
mCherry, a red fluorescent protein (RFP), and plasmid
pGLY10970 includes yEGFP3, a green fluorescent pro-
tein (GFP), both regulated by the constitutive TEF pro-
moter and the AOX1 transcription terminator. The
plasmids also comprise the URA6 ORF as an integration
locus. By linearizing at the unique SpeI restriction site
within URA6 region, both vectors are integrated into the
URA6 genomic locus via single crossover.
Table 1 lists the yeast strains used in this study.
As shown in Figure 2, plasmids pGLY10969 and
pGLY10970 were separately transformed into a parental
strain to obtain two haploid strains. The diploid strains
were constructed by mating these haploids followed











































Figure 1 (See legend on next page.)
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Figure 1 Vectors for anti-HER2 light-chain and heavy chain expression. (a) Plasmid pGLY10969 encodes the light chain of anti-HER2
antibody and mCherry red fluorescent protein in association with the arsenic resistance selection marker and targets the URA6 locus in P. pastoris
genome (b) Plasmid pGLY10970 encodes the heavy chain of anti-HER2 antibody and yEGFP3 green fluorescent protein in association with
nourseothricin resistance selection marker and targets the URA6 locus in P. pastoris genome. (c) Plasmid pGLY6830 encodes both light-chain and
heavy-chain of anti-HER2 expression cassettes in association with zeocin resistance selection marker and targets to the TRP2 locus in P. pastoris
genome. The SpeI restriction enzyme site used to linearize each vector prior to yeast transformation is underlined.
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into the URA6 locus, haploid progeny resulting from
diploid sporulation could contain only one of the two
expression cassettes. Consequently, only diploid cells
were both nourseothricin and arsenic resistant (NAT+
/ARS+), simultaneously expressed GFP and RFP, and
secreted fully-assembled anti-HER2 antibody into the
media. These features facilitated the monitoring of diploid
population stability by using flow cytometry and selection
plate methods, and were later used in the quantitative esti-
mation of diploid population during the protein expres-
sion process.
We used a filter-based mating protocol to determine
the maximum mating efficiency in P. pastoris. We esti-
mated that the maximum mating efficiency for the wild-Table 1 Yeast strains used in this study
Strain Ploidy Parent Plasmid Glycan
NRRL-Y11430 haploid N/A N/A wi
YGLY2-3 haploid N/A N/A o
YGLY8292 haploid N/A N/A GS2.
YGLY8316 haploid N/A N/A GS5
YGLY27429 haploid NRRL-Y11430 pGLY10969 wi
YGLY27430 haploid NRRL-Y11430 pGLY10970 wi
YGLY27431 diploid YGLY27429/YGLY27430 N/A wi
YGLY27432 haploid NRRL-Y11430 pGLY10969 pGLY10970 wi
YGLY27433 haploid YGLY8292 pGLY10969 GS2.
YGLY27434 haploid YGLY8292 pGLY10970 GS2.
YGLY27435 diploid YGLY27433/YGLY27434 N/A GS2.
YGLY27436 haploid YGLY8292 pGLY10969 pGLY10970 GS2.
YGLY13979 haploid YGLY8316 pGLY6830 GS5
YGLY19313 haploid YGLY13979 N/A GS5
YGLY19853 haploid YGLY19313 pGLY24 GS5
YGLY19895 diploid YGLY19313/YGLY19853 N/A GS5
*Detailed strain genotype is described in Materials and Methods.
Man5: Man5GlcNac2;
G2: Gal2GlcNAc2Man3GlcNAc2;type haploid P. pastoris strain (NRRL-Y11430) is about
10-2 (i.e. 1%, 1 diploid per 100 haploid cells) after 3 days,
25°C mating plate incubation. We reduplicated the filter
mating experiment with och1Δ glyco-engineered strains
and found that the mating efficiencies of both the och1Δ
strain (YGLY2-3) and the GS2.0 strain (YGLY8292) are
around 10-3 (i.e. 0.1%, 1 diploid per 1000 haploid cells).
Not only did the och1Δ strains show a 10-fold decrease
in maximum mating efficiency, but cells additionally
required 5 days of mating plate incubation to reach
maximum fusion (Table 2).
It should be noted that we calculated the mating effi-
ciency based on the number of selective growth of crossed
diploids using complementary markers. Because cells of
the same strain could also mate, the total number ofStructure Genotype
ld-type OCH1 wild-type N-glycan P. pastoris
ch1Δ och1- N-glycan P. pastoris
0 (Man5) och1- glycoengineered GS2.0 starting strain*
.0 (G2) och1- glycoengineered GS5.0 starting strain*
ld-type URA6::AOX1p-anti-HER2-Lc, TEFp-mCherry, Ars
ld-type URA6::AOX1p-anti-HER2-Hc, TEFp-GFP, Nat
ld-type URA6::AOX1p-anti-HER2-Lc, TEFp-mCherry, Ars
URA6::AOX1p-anti-HER2-Hc, TEFp-GFP, Nat
ld-type URA6::AOX1p-anti-HER2-Lc, TEFp-mCherry, Ars
URA6::AOX1p-anti-HER2-Hc, TEFp-GFP, Nat
0 (Man5) URA6::AOX1p-anti-HER2-Lc, TEFp-mCherry, Ars
0 (Man5) URA6::AOX1p-anti-HER2-Hc, TEFp-GFP, Nat
0 (Man5) URA6::AOX1p-anti-HER2-Lc, TEFp-mCherry, Ars
URA6::AOX1p-anti-HER2-Hc, TEFp-GFP, Nat
0 (Man5) URA6::AOX1p-anti-HER2-Lc, TEFp-mCherry, Ars
URA6::AOX1p-anti-HER2-Hc, TEFp-GFP, Nat
.0 (G2) TRP2::AOX1p-anti-HER2-Lc, AOX1p-anti-HER2-Hc, Zeocin
.0 (G2) TRP2::AOX1p-anti-HER2-Lc, AOX1p-anti-HER2-Hc, Zeocin, ura5-
.0 (G2) TRP2::AOX1p-anti-HER2-Lc, AOX1p-anti-HER2-Hc, Zeocin, arg3-
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Figure 2 Schematic overview of P. pastoris haploid strain construction, mating, and selection of anti-HER2 antibody expressing diploid
strains.
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reported here when self-mated diploids were included.
Confirmation of mated diploids was accomplished by
colony PCR (cPCR) using the primer sets specific to the
anti-HER2 light chain and heavy chain listed in Table 3.
Figure 3 verifies that diploid strains contain genetic ele-
ments from both parental haploids. Lanes 1 and 2 of
Figure 3a show that cPCR of the heavy-chain containingTable 2 Mating efficiency of OCH1 wild-type and glycoengine
Parental Haploid Strain Glycan Structure Mating Condition D
NRRL-Y11430 OCH1 wild-type 3 days, 25°C
NRRL-Y11430 OCH1 wild-type 3 days, 25°C
NRRL-Y11430 OCH1 wild-type 3 days, 25°C
NRRL-Y11430 OCH1 wild-type 3 days, 25°C
YGLY2-3 och1Δ 5 days, 25°C
YGLY2-3 och1Δ 5 days, 25°C
YGLY2-3 och1Δ 5 days, 25°C
YGLY8292 GS2.0 (Man5) 5 days, 25°C
YGLY8292 GS2.0 (Man5) 5 days, 25°C
YGLY8292 GS2.0 (Man5) 5 days, 25°C
YGLY8292 GS2.0 (Man5) 5 days, 25°C
YGLY8316 GS5.0 (G2) 5 days, 25°C
YGLY8316 GS5.0 (G2) 5 days, 25°C
YGLY8316 GS5.0 (G2) 5 days, 25°C
YGLY8316 GS5.0 (G2) 5 days, 25°C
*ura5- strain has a slow growth phenotype.haploid strains (YGLY27430 and YGLY27434) produced
a band using the heavy-chain specific primer set and no
product was generated in light-chain containing haploid
strains (YGLY27429 and YGLY27433). Likewise, lanes 3
and 4 of Figure 3b show that cPCR of the light-chain
containing haploids (YGLY27429 and YGLY27433) pro-
duced a band using the light-chain specific primer set
and no product was seen in heavy-chain only haploids.ered P. pastoris strains












Zeocin, ARS 2.5 × 10-4
Zeocin, NAT 2.5 × 10-4
ARS, NAT 2.5 × 10-4
Arg3, Ura5 10-5 *
Table 3 Primers used to confirm the existence of anti-HER2 light and heavy chains in diploid genome
Reaction Primer Name Primer Sequence (5' to 3') Primer Description Product
PCR-Hc MT3 GGTTCCAATTGACAAGCTTTTGATTTTAACG AOX1p_Forword 970 bp
MT126 GTCCTCGTGAGAAACGTC Anti_HER2_Hc_Reverse
PCR-Lc MT3 GGTTCCAATTGACAAGCTTTTGATTTTAACG AOX1p_Forword 580 bp
MT132 CTCTCTTGGGTAGAAGTTGTTCAACAA Anti_HER2_Lc_Reverse
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loid colonies obtained from the mating of YGLY27430/
YGLY27429 and YGLY27434/YGLY27433, where the
presence of anti-HER2 heavy-chain and light-chain ex-
pression cassettes in the genome was confirmed by
cPCR. Several hundred colonies from each mating reac-
tion were analyzed by cPCR, revealing that more than(a)
Haploid strain (GS2.0) contYGLY27434 2 
Haploid strain (OCH1 wildYGLY27429 3 
Diploid strains obtained from the mating of YG
both anti-Her2 heavy chain + light chain in the 
8-10 
Diploid strains obtained from the mating of YG
both anti-Her2 heavy chain and light chain in th
5-7 
Haploid strain (GS2.0) contYGLY27433 4 
Haploid strain (OCH1 wildYGLY27430 1 







Figure 3 PCR and microscopy confirmation of diploid polyploidy. For
existence of anti-HER2 light and heavy chain expression cassettes in the di98% of colonies growing on selection media were
diploid. Figure 3c displays representative microscopy
fluorescence observations of wild-type haploid strains
YGLY27430, YGLY27429 and their crossed diploid
strain YGLY27431. Similar microscopy fluorescence was
observed in the glycoengineered strain background (data
not shown).(b)
aining anti-Her2 heavy chain only. 
 type) containing anti-Her2 light chain only. 
LY24733 and YGLY24734. Diploid strains contain 
genome. 
LY24730 and YGLY24729. Diploid strains contain 
e genome. 
aining anti-Her2 light chain only. 
 type) containing anti-Her2 heavy chain only. 
Light-chain specific cPCR 
1 2 3 4 5 6 7 8 9 10
ence red fluorescence 
a, and b, the primer sets listed in Table 3 were used to confirm the
ploid chromosome.
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combinations of the dominant markers Zeocin, NAT,
and ARS as well as the auxotrophic markers ARG1,
ARG3, HIS1, HIS4, and URA5. In all tested mating cir-
cumstances, the mating efficiency in all och1Δ strains
was found to be around 0.1% (Table 2), irrespective of
the glycoengineered strains (GS2.0, and GS5.0). In wild-
type P. pastoris, N-glycan structures consist mostly of
Man15-30 with varying degrees of charged glycans. By
comparison, N-glycans of och1Δ mutant strain are pre-
dominantly Man8-12, representing a noticeable shift to
smaller glycans due to the lack of the outer chain [7].
Our results suggest that the knockout of och1 decreases
mating efficiency by 10 fold, likely because of decreased
levels of mannose proteins in the och1Δ mutants, and
that further glycoengineering has a negligible impact on
mating fitness.
Recombinant anti-HER2 production and diploid strain
stability in methanol
To understand heterologous protein production in diploid
P. pastoris strains and diploid stability in methanol media,
diploid yeasts YGLY27431 (wild-type) and YGLY27435
(och1, GS2.0) were induced in 2% BMMY methanol media
for 72 hours in shake flasks for anti-HER2 production.
Diploid strain stability was quantitatively determined
by analyzing the percentage of diploid cells in the
total cell population at 12 hr time intervals. The red
curve in Figure 4a depicts the diploid population
percentage of YGLY27431 over the 72 hour methanol
induction period. The diploid population was main-
tained at around 100% throughout the entire metha-
nol induction time. No obvious sporulation events
were observed. Similarly, a stable diploid population
was observed in the glycoengineered strain YGLY27435
(Figure 4a, blue curve).Figure 4 Diploid strain stability analysis. (a) Diploid strain stability show
methanol induction phase over 72 hour induction time course. (b) Time-de
a, and b, percentage of diploid population was determined by the numbe
the number of colonies growing in a non-selective plate. Symbols represen
controls, parental haploid strains carrying either ARS or NAT selection mark
arsenic and nourseothricin (data not shown).We applied the same plate-based stability assay to
examine diploid strain stability in nitrogen-deprived
sporulation media. Figure 4b shows the diploid popula-
tion in strains YGLY27431 and YGLY27435 in a
nitrogen-deprived environment. A significant number of
sporulation events were observed in the wild-type dip-
loid strain YGLY27431 after 48 hrs in sporulation media
(Figure 4b, red curve). After 72 h incubation, only about
40% of the cell population retained a diploid pheno-
type. Meanwhile, the glycoengineered diploid strain
YGLY27435 (blue curve) appeared to sporulate at much
lower frequency. This observation was consistent with a
previous report in a S. cerevisiae och1Δ/och1Δ diploid
strain where sporulation was reported to occur at a
reduced efficiency [23].
It is worth mentioning that because P. pastoris asci
contain up to 4 haploid ascospores, 1 diploid sporulation
event might therefore generate up to 4 survival colonies
on the non-selection plate if the spores are well sepa-
rated. As a result, our plate-based stability curves reflect
a relative but sensitive method to monitor diploid stabil-
ity rather than absolute sporulation frequencies. In the
case of Figure 4b data, 40% of the total diploid popula-
tion could be caused by merely 25% of diploid cells
undergoing sporulation, assuming that all P. pastoris
spores were disjointed.
Diploid stability was also analyzed using flow cytome-
try. Figure 5a and 5b depict the green and red fluores-
cence profiles of the haploid yeast strains YGLY27430
(GFP-expressing only) and YGLY27429 (RFP-expressing
only), respectively. Both haploids formed a distinct and
highly fluorescent population distribution in their corre-
sponding color channels. Figure 5c displays the fluores-
cence profiles of the diploid strain YGLY27431 and
Figure 5d shows the fluorescence profiles of the diploid
strain YGLY27431 under methanol induction over aing total diploid population percentage in shake flasks followed by a
pendent diploid stability in nitrogen-deprived sporulation media. For
r of colonies growing on a diploid selection plate in comparison with
t the average measurement values from triplicate experiments. As
er did not form any colonies on selection plates containing both
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Figure 5 (See legend on next page.)
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Figure 5 Evaluation of diploid strain stability using flow cytometry analysis. (a) Green and red fluorescence intensities of parental haploid
yeast strain YGLY27430 (expressing only GFP). (b) Green and red fluorescence intensities of parental haploid yeast strain YGLY27429 (expressing
only RFP). (c) Green and red fluorescence intensities of diploid yeast strain YGLY27431 (expressing both GFP and RFP). (d) Time course of green
and red fluorescence intensities of diploid yeast strain YGLY27431 in shake-flask, methanol induction media. Fluorescence intensities were
measured at 24-hour time intervals. (e) Fluorescence intensities of diploid yeast strain YGLY27431 after 72 hours cultivation in nitrogen-deprived
sporulation media. For a, b, c, d and e, all yeast strains contained OCH1 wild-type N-glycan. Similar flow cytometry profiles were also observed in
several different GS2.0 strain lineages YGLY27433, YGLY27434, and YGLY27435 (data not shown).
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strong GFP and RFP co-expression profiles throughout
the 72 hour methanol induction period, suggesting that
the diploid strains were stable under the conditions
tested.
As a control experiment, when incubated for 72 hrs
in nitrogen-deprived sporulation media, diploid cells
formed two distinctive population distributions in both
green and red fluorescence channels (Figure 5e). The
high green fluorescence cell population corresponded to
the vegetative diploid population, and the lower green
fluorescence cell population could be explained by pro-
tein degradation during the sporulation process or lysis
of the anucleate mother cell. Both green and red fluores-
cence profiles of the flow cytometry experiment pro-
vided reliable, real-time monitoring of diploid strain
stability. Similar flow cytometry results were observed in
the glycoengineered diploid strain YGLY27435 (data not
shown).
Bio-analytical characterization of anti-HER2 produced in
diploid P. Pastoris strains
Figure 6a shows the reducing and non-reducing SDS-
PAGE for anti-HER2 material generated by diploid
P. pastoris strains and their comparison with anti-HER2
material generated by haploid P. pastoris strains and
commercial trastuzumab. Anti-HER2 produced by dip-
loid P. pastoris strains was well assembled and included
the expected tetramer of two heavy and two light chains.
An intact protein mass analysis was confirmed by liquid
chromatography-mass spectrometry (LC-MS) after re-
lease of the N-glycan (Figure 6b). HER2 target binding
of P. pastoris produced anti-HER2 was verified by sur-
face plasmon resonance (Table 4). Similar kinetic bind-
ing constants were found for anti-HER2 produced in
both diploid and haploid P. pastoris strains.
Bioreactor cultivations of P. Pastoris diploids
We examined fermentability of diploid P. pastoris strains
YGLY27431 (wild-type) and YGLY27435 (och1, GS2.0)
using a simple fed-batch, carbon-limited 3 Liter fermen-
tation platform. As shown in Figure 7a and 7b, both
strains displayed an increase in antibody titer and WCW
over a 10 day methanol induction time course. The
anti-HER2 titers of diploid strains YGLY27431 andYGLY27435 at harvest were 227 mg/L and 148 mg/L, re-
spectively under the suboptimal, constant feed rate fer-
mentation conditions. The non-reducing SDS-PAGE in
Figure 7c and 7d shows the high quality of fully
assembled anti-HER2 material produced.
We analyzed diploid stability using both a plate-based
stability assay and flow cytometry (Figure 8 a-c), and we
observed a steady decrease in the diploid population
(i.e. increasing sporulation) over time. After 10 days of fer-
mentation, the percentage of diploids in the populations
for YGLY27431 and YGLY27435 were 50% and 70%,
respectively.
FACS analysis suggested that vegetative growing GFP
or RFP expressing haploid populations in culture media
were minimal. The sporulated diploids mostly existed in
dormant spore states. Moreover, our previous experience
showed that Protein A is able to capture heavy chain
monomer. In Figures 7a and 7b, there is no obvious
heavy chain monomer band after protein A purification,
inferring that the haploids population is not significant.
We used cPCR to corroborate the existence of vegeta-
tive diploid and sporulated populations during fermenta-
tion. Figure 8d shows the cPCR results from 10
randomly picked colonies of YGLY27431 fermentation
samples (10 days) growing on ARS/NAT selection plates.
All colonies produced the PCR bands of anti-HER2
heavy and light chains, confirming their diploid geno-
type. Confirmation of ascospore formation in fermenta-
tion samples was done using diethyl ether extraction
followed by cPCR. The cPCR result of 18 randomly
picked colonies of diethyl ether treated YGLY27431 fer-
mentation samples revealed that colonies contained ei-
ther the heavy chain or light chain sequence in its
genome but not both, confirming their haploidy. Similar
cPCR results were observed in YGLY27435 fermentation
samples (data not shown).
Comparison of recombinant protein production between
haploids and isogenic diploids
The above results show that both wild-type and glyco-
engineered P. pastoris diploid strains are able to provide
efficient and reliable anti-HER2 protein production in an
established carbon-limited fermentation process. Our
next aim is to perform a head-to-head assessment of re-
combinant protein production in a haploid P. pastoris
ll
l
Figure 6 Characterization of diploid P. pastoris-derived antibody. (a) SDS-PAGE showing the quality of an anti-HER2 antibody produced in
diploid P. pastoris strains in comparison with anti-HER2 material produced in haploid P. pastoris strains and their comparison with trastuzumab
produced from CHO cells. (b) LC-MS mass spectrometry of anti-HER2 antibodies after release of N-glycan. For a, and b, anti-HER2 material
produced in yeast strains was purified by affinity capture using protein A beads.
Table 4 Kinetic binding constants of P. pastoris produced
anti-HER2
Samples Description ka (1/M*s) kd (1/s) KD (nM) Ave. KD (nM)
YGLY27431 OCH1 wild-type,
diploid
4.0E + 4 1.9E-4 4.7 4.63
YGLY27432 OCH1 wild-type,
haploid
4.4E + 4 1.8E-4 4.2
YGLY27435 GS2.0, diploid 4.1E + 4 2.2E-4 5.3
YGLY27436 GS2.0, haploid 3.9E + 4 1.7E-4 4.3
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clone using N-glycan quality and protein titer as read-
outs. The haploid strain YGLY13979 was constructed by
transforming plasmid pGLY6830 (Figure 1c) encoding
both the light chain and heavy chain of anti-HER2 regu-
lated by the AOX1 promoter into strain YGLY8316 [24].
Glycoproteins expressed in this strain were decorated
with biantennary complex N-linked glycans.
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Figure 7 Time course of protein productivity, biomass, and SDS-PAGE of diploid yeast strains YGLY27431 and YGLY27435 under fed-
batch high-cell-density fermentation. (a) Anti-HER2 productivity showing HPLC broth titer as a function of time. (b) Biomass showing WCW as
a function of time. (c) Non-reducing SDS-PAGE of Protein-A captured YGLY27431 fermentation product. (d) Non-reducing SDS-PAGE of Protein-A
captured YGLY27435 fermentation product.
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diploid of YGLY13979, using URA5 and ARG3 auxo-
trophic markers as described in Methods. Table 5 lists
the comparison of protein titer and glycan quality pro-
duced in strains YGLY13979 and YGLY19895 in a 1 L
scale fermentor (n = 3). The diploid strain YGLY19895
had comparable broth titers to its haploid P. pastoris
production counterpart (94% titer, within normal range
deviation, n = 3). Moreover, anti-HER2 purified from the
strains showed a very similar N-linked glycosylation pro-
file (Table 5). Based on these observations, we suggest
that diploid P. pastoris has the potential to produce pro-
teins with high N-glycan quality.
Generation of a yeast antibody display library by mating
The construction of a yeast antibody display library by
mating is dependent on the successful selection of ap-
propriate strains and vectors. To facilitate large-scale
diploid selection and cultivation of mated diploid cells,
we chose the auxotrophic markers HIS1 and ARG1 for
the selection of heavy and light chain vectors, respect-
ively. As a proof-of-concept experiment, the host strain
used was a his1Δ arg1Δ double auxotrophic wild-type
strain. In this experiment, diploids were conveniently
selected by growth in minimal liquid media without
amino acid supplement. Compared with the strain selectionusing dominant drug markers, the use of auxotrophic
makers eliminates the possibility of revertants that might
arise through drug resistance.
We started with rationally designed heavy and light
chain CDR3 variant libraries of an antibody with a
known affinity for its antigen. The designed libraries
contained >4,000 heavy-chain variants and >1,200 light-
chain variants, where S. cerevisiae SED1 (GPI-cell wall
glycoprotein) was used as a cell surface display anchor
(Shaheen et al., manuscript in preparation). Through
mating of heavy and light chain P. pastoris haploid li-
braries, a diploid library containing more than 108 col-
onies was successfully constructed and covered more
than 10 times theoretical diversity.
We sequenced several hundred colonies, and all clones
exhibited non-identical CDR3 sequences, supporting the
diversity of the designed library (data not shown). In this
proof-of-concept mating experiment conducted in wild-
type P. pastoris, we estimated the mating efficiency to be
around 0.25%. We successfully utilized this novel P. pas-
toris display system to identify a new antibody lead with
improved biochemical characteristics and binding affin-
ity using fluorescence activated cell sorting (manuscript
in preparation). Our future plans include scaling up the
current mating protocol to achieve a library with a diver-
sity of 1010.
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Figure 8 Diploid strain stability in high-productivity fed-batch fermentation. (a) Time course green and red fluorescence intensities of
YGLY27431 showing OCH1 wild-type P. pastoris diploid strain stability over 10 days of induction. (b) Time course green and red fluorescence
intensities of YGLY27435 showing glycoengineered -P. pastoris diploid strain stability over 10 days of induction. (c) Time-dependent diploid strain
stability analyzed using a selection plates assay. (d) PCR confirmation of diploid genome. (e) PCR confirmation of sporulated haploid genome. For
a, and b, fluorescence intensities were measured at 24-hour time interval using flow cytometry. For c, percentage of diploid population was
determined by the number of colonies growing in diploid selection plate in comparison with the number of colonies growing in non-selective
plates. For d, and e, the primer sets listed in Table 3 were used to confirm the existence of anti-HER2 light and heavy chain expression cassettes
in yeast chromosome.
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Table 5 Fermentation profiles of haploid yeast strain YGLY13979 in comparison with its homozygous diploid strain
YGLY19895
Strain Ploidy Supernatant HPLC Titer (mg/L) Broth Titer (mg/L) WCW (g/L) Induction Time (hr)
YGLY13979 Haploid 1048 780 255 96
YGLY19895 Diploid 920 730 206 96
Strain Ploidy Man5% G0% G1% G2% Hybrid % Complex %
YGLY13979 Haploid 13.3 60.1 16.8 3.8 6.0 80.7
YGLY19895 Diploid 15.6 59.1 15.1 2.5 7.7 76.7
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In a previous effort to humanize the protein glycosyla-
tion pathway in the yeast P. pastoris, we developed a sys-
tematic fusion library approach to select for the proper
combination of targeting signal and catalytic domains.
By sequentially screening several combinatorial genetic
libraries to properly localize active eukaryotic mannosi-
dases and glycosyltransferases, we were able to engineer
the yeast glycosylation pathway to produce N-glycans
with human-like glycan structures [7-13]. The genetic
manipulations required for the construction of such
strains were laborious and time-consuming.
Many species of yeasts, including P. pastoris, are mat-
ing competent. Mating enables two distinct haploid
strains to fuse and generate a diploid strain possessing
genetic elements from both parental haploids. Mating
diploid yeast strains therefore potentially provides a con-
venient and faster route for strain construction and con-
solidation. Conventional experience that diploid P.
pastoris strains are unstable suggests that after mating,
immediate sporulation followed by screening stable hap-
loid strains carrying desirable genetic constructs is im-
perative. Since the haploid P. pastoris genome contains
only 4 chromosomes, gene integration loci are com-
monly linked to some degree and are presumably not
well-segregated during sporulation. Strain construction
using mating hence requires carefully chosen integration
loci and the number of genes of interest can be limited
by available selection markers.
By using protein titer and N-linked glycosylation profiles
as quantitative readouts, we demonstrate that diploid P.
pastoris strains offer comparable protein productivity and
N-glycosylation profile to that of a haploid strain expres-
sing the same antibody. Our comparison is based on
isogenic homozygous diploid strains. Through careful se-
lection of desired characteristics for mating, we consider it
a possibility to construct heterozygous diploid P. pastoris
strains possessing superior productivity and better stress
tolerance than parental haploids. Polyploidy yeast strainsmay further be constructed through spheroplast fusion.
This work lays a foundation for using mating for complex
P. pastoris strain consolidation and direct screening of
mated diploids for large-scale protein production. This
method will be especially suitable for the systematic
screening of combinatorial genetic libraries, and the num-
ber of genes of interest will not be limited by accessible se-
lection markers.
Improved diploid bioreactor stability can be achieved
through process and media optimization. In our experi-
ments, both shake flask cultivation and fed batch fer-
mentation were done using the same complex nutrient
rich media. There were two major differences between
shake flask and fermentation conditions: cell population
density and media replenishment. In a shake flask, the
start of induction cell population density was much
lower than fed batch fermentation. This was indicated
by a measured OD of 1–5 in shake flask versus 150–200
in fed batch fermentation. Additionally, culture media
was replaced at start of induction in shake flask cultiva-
tion; while same media was carried over from growth
phase into induction in fed batch fermentation. Due to
both above stated reasons, the nutrient levels in fed
batch fermentation would be lower than shake flask
cultivation.
Based on available evidence, the authors believe that
the addition of supplemental N-source can improve the
performance of diploids in fed batch. Other fermentation
modes such as perfusion and continuous culture may
help in improving diploid stability. Alternatively, genetic
engineering approach can be applied to obtain stable
diploid P. pastoris cell lines. For example, the knockout
of IME1, a key transcriptional regulator of early meiotic-
specific genes, should abolish sporulation and stabilize
diploid cell lines [25,26]. Considering that sporulation
regulator genes are usually repressed under normal
growth condition, we speculate that mutant ime1Δ, or
other sporulation negative genes will have minimal
effects on the AOX1 promoter activity or mating.
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practical and productive means for selecting higher af-
finity and well expressing antibodies using fluorescence
activated cell sorting [27,28]. S. cerevisiae is presently
the preferred expression host and has been successfully
used for the isolation of antibody leads against a wide
range of target antigens. However, the existence of fun-
gal type N-glycans within the variable-region can still
cause artifacts and have a negative impact on antibody
selection [29]. Further development of the yeast anti-
body display system will require replacing fungal type
N-linked glycans with mammalian-type N-glycans. With
the uniform N-glycan profile generated by humanized P.
pastoris, the glycoengineered P. pastoris display system
provides a unique opportunity to leverage variable-
region glycosylation in mAb discovery. An antibody
display library containing N-linked glycosylation in
variable-region can be rationally designed by introducing
a consensus N-linked glycan motif (Asn-X-Ser or Thr,
where X 6¼Pro) throughout the CDRs. N-link glycosyla-
tion can also be generated by using random mutagenesis
approaches. We postulate that an antibody variable-
region glycosylation library constructed like this will be
especially suitable for affinity maturation, where anti-
bodies with increased affinity for antigen are selected.
We demonstrate that by utilizing P. pastoris mating it is
feasible to generate relatively large yeast antibody librar-
ies from easily constructed small libraries of heavy and
light chains. Future development of glycoengineered P.
pastoris system will ultimately enable a unique expres-
sion host, streamlining discovery, optimization, and
production.
Conclusions
The main purpose of this study is to investigate
utilization of diploid P. pastoris strains for heterologous
protein expression and to understand diploid strain sta-
bility in high-productivity fermentation. By using an
anti-HER2 monoclonal antibody as a target protein, we
demonstrate that recombinant protein production in
both wild-type and glycoengineered P. pastoris diploids
is stable and efficient using a nutrient rich shake flask
cultivation. When the diploid strains were cultivated
under bioreactor conditions, sporulation was observed.
Still, both wild-type and glycoengineered P. pastoris
diploids showed robust productivity and secreted recom-
binant antibody with high quality. We further demon-
strate that diploid P. pastoris strains offer comparable
protein productivity and N-glycosylation profile to that
of a haploid strain expressing the same antibody.
During manuscript preparation, the authors found two
U.S. patent applications describing the use of Pichia pas-
toris diploids submitted by another group of researchers
[30,31]. Still, to the best of our knowledge, this studyreports for the first time a comprehensive characteri-
zation of recombinant protein expression and fermenta-
tion using diploid P. pastoris strains. Data presented
here support the use of mating for various applica-
tions including strain consolidation, variable-region
glycosylation antibody display library, and process
optimization.
Methods
Reagents & construction of anti-HER2 mAb expression
plasmids
Escherichia coli strains TOP10 or XL10-Gold were used
for recombinant DNA work. PNGase F, DNA restriction
and DNA modification enzymes were obtained from
New England BioLabs (Ipswich, MA). Figure 1 illustrates
plasmid maps of anti-HER2 expression vectors used in
this study. Anti-HER2 heavy and light chain genes (Her-
ceptinW monograph, www.rochecanada.com) were codon
optimized for P. pastoris expression and synthesized
from GeneArt (Regensburg, Germany). Green fluores-
cent protein yEGFP3 [32] and red fluorescent protein
mCherry [33] were codon optimized and synthesized
from Genscript (Piscataway, NJ).
Plasmid pGLY10969 (Figure 1a) was a roll-in integra-
tion plasmid encoding the light chain of the anti-HER2
antibody and mCherry red fluorescent protein that tar-
geted the URA6 locus in P. pastoris. The antibody light
chain expression cassette used methanol inducible
AOX1 promoter and TEF transcription terminator
sequences. S. cerevisiae alpha-mating factor signal se-
quences were applied to light chain as secretion signal
peptide. The RFP expression cassette used constitutive
TEF promoter and AOX1 transcription terminator
sequences. The selection of transformants used arsenic
resistance (ARS) encoded by the S. cerevisiae ARR3 ORF
under the control of the P. pastoris RPL10 promoter and
S. cerevisiae CYC1 transcription terminator sequences.
The plasmid further included a nucleic acid molecule
for targeting the URA6 locus.
Plasmid pGLY10970 (Figure 1b) was a roll-in integra-
tion plasmid encoding the heavy chain of anti-HER2
antibody and yEGFP3 green fluorescent protein that tar-
geted the URA6 locus in P. pastoris. The antibody heavy
chain expression cassette used methanol inducible
AOX1 promoter and TEF transcription terminator
sequences. S. cerevisiae alpha-mating factor signal
sequences were applied to heavy chain as secretion sig-
nal peptide. The GFP expression cassette used constitu-
tive TEF promoter and AOX1 transcription terminator
sequences. The selection of transformants used nourseo-
thricin resistance encoded by the Streptomyces noursei
nourseothricin acetyltransferase (NAT) ORF under the
control of the Ashbya gossypii TEF1 promoter and Ash-
bya gossypii TEF1 terminator sequences. The plasmid
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the URA6 locus.
Plasmid pGLY6830 (Figure 1c) was a roll-in integra-
tion plasmid encoding both the light and heavy chains of
anti-HER2 antibody that target the TRP2 locus in P. pas-
toris. Both the heavy and light chain expression cassettes
used methanol inducible AOX1 promoter and AOX1
transcription terminator sequences. S. cerevisiae alpha-
mating factor signal sequences were applied to both
heavy and light chain as secretion signal peptide. For
selecting transformants, the plasmid comprised an ex-
pression cassette encoding the Zeocin selection marker
controlled by S. cerevisiae TEF promoter and S. cerevi-
siae CYC1 transcription terminator sequences. The plas-
mid further includes a nucleic acid molecule for
targeting the TRP2 locus.
Yeast strains
Table 1 lists the yeast strains used in this study. All gly-
coengineered P. pastoris expression strains used were
constructed from wild-type P. pastoris strain NRRL-
Y11430 (Northern Regional Research Laboratories, Pe-
oria, IL) using methods as described in [7,11,13].
The starting GS2.0 strain for the mating construction
of recombinant anti-HER2 expression was YGLY8292
[och1Δ, bmt1Δ, bmt2Δ, bmt3Δ, bmt4Δ, mnn4L1Δ,
pno1Δ, mnn4Δ, Kluyveromyces lactis & Mus musculus
UDP-GlcNAc transporters, Trichoderma reesei α-1,2-
MnsI]. Glycoproteins expressed from this strain lineage
are decorated with Man5 glycans.
The starting GS5.0 glycoengineered strain for the con-
struction of the recombinant anti-HER2 expression was
YGLY8316 [24]. Glycoproteins expressed in this strain
are decorated with biantennary complex, galactosylated
(G2) glycans.
The plasmids encoding the light chain and heavy chain
of the anti-HER2 antibody were linearized with SpeI to
favor the integration at TRP2 or URA6 locus of P. pas-
toris genome and transformed into yeast by electropor-
ation. Yeast strains YGLY27429 and YGLY27433 were
generated by transforming pGLY10969, which encoded
the light chain of anti-HER2 antibody and mCherry red
fluorescent protein into P. pastoris wild-type strain
NRRL-Y11430 and glycoengineered GS 2.0 strain
YGLY8292, respectively. Yeast strains YGLY27430 and
YGLY27434 were generated by transforming pGLY10970,
which encoded the heavy chain of anti-HER2 antibody
and GFP green fluorescent protein into wild-type strain
NRRL-Y11430 and glycoengineered GS 2.0 strain
YGLY8292, respectively.
Diploid yeast strain YGLY27431 was generated from
the mating of YGLY27429 and YGLY27430; this strain
contains OCH1 wild-type N-glycan structure. GS2.0 dip-
loid yeast strain YGLY27435 was generated from themating of YGLY27433 and YGLY27434. Haploid anti-
HER2 producing yeast strains YGLY27432 and
YGLY27436 were obtained by double transformation of
plasmids pGLY10969 and pGLY10979 into NRRL-
Y11430 and YGLY8292, respectively. The strains com-
prised both anti-HER2 heavy and light chain expression
cassettes and were used as anti-HER2 producing haploid
control strains.
Yeast strain YGLY13979 [24] was generated by trans-
forming pGLY6830, which encoded both heavy and light
chains of anti-HER2 antibody, into the glycoengineered
GS5.0 strain YGLY8316. The URA5 gene of the proto-
troph YGLY13979 was flanked by two lacZ repeats
introduced during the strain construction procedure.
Strain YGLY13979 was counter-selected in the pres-
ence of 5-fluoroorotic acid (5-FOA) to produce the yeast
strain YGLY19313 in which the URA5 gene was lost and
only one copy of lacZ repeat remains in the chromo-
some. This rendered the strain auxotrophic for uracil.
Afterwards, strain YGLY19313 was transformed with
pGLY24 [34], a ARG3 knockout vector using URA5 as a
selectable marker. This rendered the strain auxotrophic
for arginine. Strain YGLY19853 was selected from the
strains produced.
Diploid yeast strains YGLY19895 was generated from
the mating of YGLY19313 and YGLY19853 using ARG3
and URA5 as selection markers. This strain, YGLY19895,
is prototrophic and contains one copy of URA5 and
ARG3 in its diploid genome. Strain YGLY19895 is con-
sidered to be an isogenic, homozygous diploid strain of
YGLY13979.
Mating and sporulation of P. Pastoris
Strains were mated using modified methods similar to
as described in [35]. In general, twenty OD600 of cells
from each parental haploid strain were combined and
spread evenly onto a 100 mm mating Petri dish (0.5%
sodium acetate, 1% potassium chloride, 1% glucose,
2% agar). For the OCH1 wild-type P. pastoris strains,
the mating reaction was allowed to proceed at 25°C
for 3 days. For the glycoengineered strains, the mat-
ing reaction condition was 25°C for 5 days. Cells were
then struck out to single colonies on diploid selection
media. Glycoengineered diploid strains were selected
on YSD plate containing 0.2 mM sodium arsenite and
25 μg/ml nourseothricin; OCH1 wild-type P. pastoris
diploids were selected with 0.5 mM sodium arsenite
and 100 μg/ml nourseothricin.
The maximum mating efficiency for the P. pastoris
strain tested was quantitatively determined using the fil-
ter method. In general, 1 OD600 of haploid P. pastoris
cells corresponded to around 107 cells. Five OD600 of
cells from each parental haploid strain were combined
and collected on the membrane surface (MF-
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0.45 μm pore, 47 mm diameter) using a vacuum filtra-
tion apparatus. The membrane was transferred cell side
up to a 100 mm mating Petri dish. After 3 days, 25°C in-
cubation (5 days for glycoengineered strains), cells were
washed away from the membrane surface. The measured
cell re-suspension OD is usually within a 1–2 fold range
of initial starting OD (i.e. 10 OD600, 10
8 cells), indicating
that cells were not actively dividing on the mating
membrane.
The mating efficiency was determined from the num-
ber of diploid colonies growing on serially diluted dip-
loid selection plates divided by (i) 108 (starting cell
numbers) and then (ii) the “fold range” of cell re-
suspension OD. The “fold range” is a number usually be-
tween 1.5 and 2. .
For the yeast display mating library construction, a
his1Δ and arg1Δ double auxotrophically marked,
OCH1 wild-type P. pastoris strain was used as the host
strain. The heavy chain and light chain libraries were
transformed separately into the above P. pastoris host.
Mating of heavy chain and light chain haploid libraries
was conducted on an agar surface (without filter) using
a 222 mm×222 mm Q-Trays Petri dish (Genetix –
Molecular Devices, Inc).
One-hundred OD600 of cells from each parental hap-
loid strain were combined and evenly spread on the
mating media agar containing 50 μg/ml histidine and ar-
ginine supplement. After 3 days, 25°C incubation, cells
were washed away from the plate surface and the diploid
antibody display library was selected in liquid minimal
media without amino acids. About 5 × 106 diploid col-
onies were obtained after one mating reaction. The cal-
culated mating efficiency here was around 0.25%.
To initiate diploid sporulation, about 50 OD600 of
freshly patched diploids cells were resuspended in
10 mL liquid sporulation media (0.5% sodium acetate,
1% potassium chloride, 1% glucose) in a 50 mL conical
tube (initial cell density = 5 OD600). The tube was incu-
bated in a temperature-controlled shaker at 25°C and
200 rpm agitation. A random spore analysis procedure
[35] was used to confirm ascospore formation in a fer-
mentation sample. Vegetative diploid cells were elimi-
nated by diethyl ether extraction and, afterwards, the
resuspended spores were serially diluted and plated on
YSD plates.
Recombinant anti-HER2 antibody expression (shake-flask)
Yeast strains were analyzed for anti-HER2 production
through small scale expression trials in 300 mL of buf-
fered 2% glycerol complex medium (Teknova, Hollister,
CA) in 1 liter shake flasks. Cell inoculums were incu-
bated at 24°C for 2 days at 200 rpm (approximate
OD600 = 1 to 5). Subsequently, the cells were pelleted bycentrifugation (1474 g for 5 min) and resuspended in
300 ml of buffered 2% methanol-complex medium
(BMMY) for induction of the AOX1 promoter. Pmt in-
hibitor PMTi4 in 100% methanol were added to the in-
duction media to a final concentration of 1.6 μg/mL to
minimize O-linked glycosylation [36]. The induction
time was carried out at 24°C for 3 days with continual
shaking at 200 rpm. The culture medium was cleared of
yeast cells by centrifugation at 15000 g for 5 min.
Bioreactor cultivations ─ carbon-limited fermentation
Bioreactor cultivations were performed in both 1 liter
Fedbatch-pro, DASGIP BioTools or 3 liter Applikon
glass bioreactors using the protocols described earlier
[6]. In the present study, Martone was replaced with
Soytone.
Purification of anti-HER2 mAb
Anti-HER2 mAb was purified using a one-step, 96-well
format STREAMLINE rProtein A method as described
in [37].
SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
SDS–PAGE was carried out according to the Laemmli
method with modified 4× non-reducing sample buffer
(250 mM Tris, pH 6.8, 8% SDS, 40% v/v glycerol, 0.4%
Bromophenol Blue sodium salt, 100 mM N-
ethylmaleimide) and 4× reducing sample buffer (250 mM
Tris, pH 6.8, 8% SDS, 40% v/v glycerol, 0.4% Bromophenol
Blue sodium salt, 20% v/v b-mercaptoethanol). Gels were
stained with 0.025% Coomassie Brilliant Blue R 250 in
7%v/v acetic acid, 40% v/v methanol and destained for
60 min in 10% v/v acetic acid.
Binding kinetic analysis with her2 extracellular domain
(ECD) protein
Surface plasmon resonance measurements of binding af-
finity using BIAcore T100 (Biosystems & ABI) were per-
formed as described in [15].
Liquid chromatography-mass spectrometry (LC-MS)
analysis
LC-MS analysis was performed on an Agilent 6520 Q-
TOF mass spectrometer connected to an Agilent 1200
HPLC system (Agilent Technologies, Santa Clara, CA).
Prior to LC-MS analysis, samples were deglycosylated by
treatment with PNGase F (New England Biolabs, Ips-
wich, MA) at 37°C for 2 hours. A Mass PREP Micro
Desalting column (Waters, Bedford, MA) was used to
remove the salts and trap the proteins in all the
experiments.
The mobile phases were 0.1% formic acid in 100%
HPLC water (Buffer A) and 0.1% formic acid in 90%
acetonitrile/10% HPLC water (Buffer B) (Fisher Scientific).
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of 1 ml/min for 2 minutes to remove salts in the sample,
and the flow was diverted to the waste line. Bound pro-
teins were eluted by running 100% Buffer B at a flow rate
of 0.4 ml/min for 5 minutes, flow was delivered to the
mass spectrometer for analysis. The column was equili-
brated by flowing through Buffer A at 1 ml/min for 3 min-
utes. Mass spectra were recorded during protein elution
at a range of 600–3000 m/z. The mass spectrometer was
operated in positive mode, the Vcap was set at 4500 V, and
the gas flow rate was set at 13 L/min at 350oC. Data was
analyzed using Agilent MassHunter Workstation Software
(Agilent Technologies, Santa Clara, CA).
Flow cytometry & microscopy
Flow cytometric analysis was performed using a BD
LSRFortessa cell analyzer equipped with 488-nm and
561-nm excitation lasers. Manufacture recommended
doublet discrimination gates in the dot plot with FSC
and SSC were applied to ensure a population of single
cells for analysis. The fluorescence intensities of the
population were measured with a 530/30 nm optical fil-
ter for GFP and with a 610/20 nm optical filter for RFP
in histograms. For each sample, 50,000 events were col-
lected, and FlowJo software was used for the analysis of
flow cytometry data.
Fluorescent microscopy observations were carried out
using a Zeiss Axio Observer Z1 epifluorescence micro-
scope equipped with a 1392 × 1040 pixel cooled Cool-
SNAP HQ2 CCD camera (Photometrics Corporation)
and a 100× objective. False coloring was performed by
capturing images with the appropriate colors (GFP fil-
ters: 436/20 excitation & 535/30 emission, RFP: 545/25
& 605/70).
Glycan characterization
PNGase F, 2-aminobenzamide (2-AB) labeling and nor-
mal phase high performance liquid chromatography
(HPLC) analysis of glycans were performed as described
in [11].
Protein A HPLC
Fermentation titer of anti-HER2 IgG1 produced from P.
pastoris was quantitatively determined using protein A
high performance liquid chromatography (HPLC).
Briefly, POROSWA perfusion chromatography column
was connected to an Agilent 1200 series HPLC with
Diode Array Detector (Santa Clara, CA, USA). The pure
mAb standard and sample were injected into a pre-
equilibrated column at flow rate of 1 mL/min, followed
by washing with PBS, pH 7.4. Anti-HER2 mAb was
eluted with elution buffer (26 mM H3PO4 in PBS, pH
2.4) and monitored by UV absorbance at 280 nm.A linear standard curve was generated by plotting the
integrated peak areas against the injected amounts of
standards. The amount of recombinant IgG in injected
samples was interpolated from the standard curve. Titer
was calculated by dividing the amount of mAb by the
injected sample volume.
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